Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
$11.04
-6.0%
$14.01
$7.05
$17.15
$308.18M0.3758,543 shs98,440 shs
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
$4.30
+10.8%
$3.95
$2.25
$8.54
$363.02M2.121.31 million shs4.57 million shs
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
$1.70
-0.6%
$1.27
$0.66
$1.90
$388.69M1.861.47 million shs3.18 million shs
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
$0.63
+1.4%
$0.66
$0.33
$0.80
$86.38M-0.14123,508 shs42,766 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
-5.96%-13.62%-26.10%-19.71%+13.81%
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
+10.82%+17.17%-10.42%+37.38%-42.36%
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
-0.58%+25.00%+31.78%+102.38%+55.96%
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
+1.44%-3.98%+6.81%+40.07%-11.42%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
1.9171 of 5 stars
3.61.00.00.03.40.80.0
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
2.0198 of 5 stars
3.41.00.00.03.00.80.6
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
3.7744 of 5 stars
3.51.00.04.72.41.70.0
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
2.2782 of 5 stars
3.55.00.00.00.01.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
3.20
Buy$23.83115.88% Upside
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
2.86
Moderate Buy$17.00295.35% Upside
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
3.00
Buy$8.25385.29% Upside
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
3.00
Buy$1.50138.51% Upside

Current Analyst Ratings Breakdown

Latest XTNT, BNTC, GOSS, and CMPS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$45.00
7/14/2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform$11.00
7/7/2025
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/23/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/23/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ In-Line$11.00 ➝ $6.00
5/27/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight$12.00
5/19/2025
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00 ➝ $28.00
5/16/2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $8.00
5/16/2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$4.00 ➝ $4.00
5/15/2025
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$20.00 ➝ $20.00
5/13/2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
N/AN/AN/AN/A$4.68 per shareN/A
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
N/AN/AN/AN/A$2.26 per shareN/A
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
$114.70M3.37N/AN/A$0.13 per share13.08
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
$117.27M0.75N/AN/A$0.31 per share2.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
-$21.75M-$1.51N/AN/AN/AN/A-38.26%-35.71%9/25/2025 (Estimated)
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
-$155.12M-$1.99N/AN/AN/AN/A-81.75%-59.42%7/30/2025 (Estimated)
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
-$56.53M-$0.23N/AN/AN/A-41.12%-128.98%-15.52%8/11/2025 (Estimated)
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
-$16.45M-$0.13N/AN/A-9.81%-27.01%-12.49%8/14/2025 (Estimated)

Latest XTNT, BNTC, GOSS, and CMPS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025Q2 2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
-$0.18N/AN/AN/A$4.12 millionN/A
8/7/2025Q2 2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
-$0.41N/AN/AN/AN/AN/A
5/15/2025Q1 2025
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
-$0.18-$0.16+$0.02-$0.16$3.95 million$9.89 million
5/14/2025Q3 2025
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
-$0.36-$0.24+$0.12-$0.24N/AN/A
5/8/2025Q1 2025
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
-$0.47-$0.44+$0.03-$0.24N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
N/AN/AN/AN/AN/A
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
N/AN/AN/AN/AN/A
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
N/AN/AN/AN/AN/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
0.01
14.80
14.80
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
0.11
10.18
10.18
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
6.70
5.71
5.71
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
0.51
2.34
1.03

Institutional Ownership

CompanyInstitutional Ownership
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
52.19%
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
46.19%
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
81.23%
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
69.33%

Insider Ownership

CompanyInsider Ownership
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
1.30%
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
3.93%
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
6.70%
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
9.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
2026.25 million25.91 millionNo Data
COMPASS Pathways PLC Sponsored ADR stock logo
CMPS
COMPASS Pathways
12093.56 million89.89 millionOptionable
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
180227.30 million212.07 millionOptionable
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
120139.32 million125.81 millionNot Optionable

Recent News About These Companies

6XTNT : A Glimpse of Xtant Medical Hldgs&#...
Xtant Medical sees Q1 revenue $32.8M-$33.1M, two estimates $30.65M

New MarketBeat Followers Over Time

Media Sentiment Over Time

Benitec Biopharma stock logo

Benitec Biopharma NASDAQ:BNTC

$11.04 -0.70 (-5.96%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$11.06 +0.02 (+0.14%)
As of 07/18/2025 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.

COMPASS Pathways stock logo

COMPASS Pathways NASDAQ:CMPS

$4.30 +0.42 (+10.82%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$4.31 +0.01 (+0.23%)
As of 07/18/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Gossamer Bio stock logo

Gossamer Bio NASDAQ:GOSS

$1.70 -0.01 (-0.58%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.68 -0.02 (-1.47%)
As of 07/18/2025 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Xtant Medical stock logo

Xtant Medical NYSEAMERICAN:XTNT

$0.63 +0.01 (+1.44%)
As of 07/18/2025 04:10 PM Eastern

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.